All In Biotech

Drug Trial Radar · NCT03049605

Effects of Electromagnetic Therapy Versus Laser Therapy on Peripheral Diabetic Neuropathy

Effects of Electromagnetic Therapy Versus Laser Therapy on Peripheral Neuropathy in Diabetic Patients

Last checked: Nov 19, 2026Latest source record: Feb 10, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

65

Actual

Start

Jan 25, 2014

Primary completion

Jan 1, 2015

Study completion Jan 1, 2017

Sponsor

Lead sponsor
Imam Abdulrahman Bin Faisal UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 10, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 35 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study are to: * Evaluate effect of magnetic therapy on peripheral neuropathy in diabetic patients. * Evaluate effect of laser therapy on peripheral neuropathy in diabetic patients. * Compare effects of magnetic therapy with that of laser therapy on peripheral neuropathy in diabetic patients.

Conditions

  • Diabetes

Interventions

  • Magnetic therapyDevice

    low intensity pulsed magnetic therapy with a frequency of 200 Hertz and intensity of 50 Gauss . Magnetic device will be applied on each patient from a comfortable supine lying position. After the connection of appliance to electrical supply, the actions of PEMF will be directed and adjusted over lumbar spine, hip regions and calf muscles of both lower limbs.

  • laser therapyDevice

    laser therapy of Helium neon infrared laser (850 nano-meter) was used in continuous wave mode from a comfortable prone lying position on the whole plantar surface of the foot and the lumbo-sacral area by four points, and two points laterally to the spine.

  • Only medical treatmentDrug

    Fifteen patients with diabetic peripheral neuropathy were treated with antidiabtic drugs and lyrica 150 milligram daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Motor and sensory conduction velocity of the lower limb nervesTime frame: 30-45 minutes

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.